Ipilimumab alone or in combination with nivolumab in patients with advanced melanoma who have progressed or relapsed on PD-1 blockade: clinical outcomes and translational biomarker analyses. - Friedman CF; Spencer C; Cabanski CR; Panageas KS; Wells DK; Ribas A; Tawbi H; Tsai K; Postow M; Shoushtari A; Chapman P; Karakunnel J; et al. (Journal for immunotherapy of cancer, 2022)